Novoheart Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Novoheart Holdings Fair Value Forecast for 2023 - 2025 - 2030
Novoheart Holdings's Price has grown In the last year, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach 0.00 – an increase of 100.00%. For the next nine years, experts predict that Novoheart Holdings's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
XENE Stock Forecast | Xenon Pharmaceuticals | Buy |
11
|
$43.75 | Buy/Sell | $51.46 | 37.14% |
AUPH Stock Forecast | Aurinia Pharmaceuticals | Outperform |
6
|
$5.10 | Buy/Sell | $13.21 | 96.08% |
ZYME Stock Forecast | Zymeworks | Outperform |
7
|
$9.20 | Buy/Sell | $13.52 | 52.17% |
EPIX Stock Forecast | ESSA Pharma | Buy |
5
|
$6.88 | Buy/Sell | $26.91 | 244.33% |
ACHF.F Stock Forecast | Arch Biopartners | - |
4
|
$1.12 | Buy/Sell | $0.00 | -100.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
CRDL Stock Forecast | Cardiol Therapeutics | Outperform |
7
|
C$2.71 | Buy/Sell | C$4.50 | 66.05% |
SVA Stock Forecast | Sernova | Outperform |
5
|
C$0.40 | Buy/Sell | C$4.07 | 725.00% |
MIST Stock Forecast | Milestone Pharmaceuticals | Outperform |
4
|
$1.69 | Buy/Sell | $10.80 | 314.20% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MDNA Stock Forecast | Medicenna Therapeutics | Buy |
0
|
C$2.39 | Buy/Sell | C$6.30 | 192.89% |
PMN Stock Forecast | ProMIS Neurosciences | Buy |
6
|
$1.96 | Buy/Sell | $18.49 | 513.27% |
BCT Stock Forecast | BriaCell Therapeutics | Outperform |
4
|
C$3.04 | Buy/Sell | C$0.00 | -100.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
IPA Stock Forecast | ImmunoPrecise Antibodies | Buy |
9
|
$1.28 | Buy/Sell | $7.00 | 446.88% |
APS Stock Forecast | Aptose Biosciences | Outperform |
9
|
C$1.64 | Buy/Sell | C$11.08 | -100.00% |
MBX Stock Forecast | Microbix Biosystems | Buy |
0
|
C$0.43 | Buy/Sell | C$0.00 | 86.05% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
IBT Stock Forecast | IBEX Technologies | - |
0
|
C$1.44 | Buy/Sell | C$0.70 | -100.00% |
TBPM.Q Stock Forecast | Tetra Bio-Pharma | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
BU Stock Forecast | Burcon NutraScience | - |
0
|
C$0.30 | Buy/Sell | C$2.50 | -100.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
COV Stock Forecast | Covalon Technologies | - |
0
|
C$1.01 | Buy/Sell | C$0.00 | -100.00% |
20B Stock Forecast | Biomark Diagnostics | - |
0
|
0.17€ | Buy/Sell | 0.00€ | -100.00% |
SBM Stock Forecast | Sirona Biochem | - |
-10
|
C$0.06 | Buy/Sell | C$0.95 | -100.00% |
Novoheart Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
Novoheart Holdings's EPS has grown In the last year, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach 0.00 – an increase of 100.00%. For the next nine years, experts predict that Novoheart Holdings's EPS will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
EDSA Stock Forecast | Edesa Biotech | Buy |
-17
|
$4.63 | Buy/Sell | $36.67 | 353.56% |
RVX Stock Forecast | Resverlogix | - |
0
|
C$0.07 | Buy/Sell | C$0.00 | -100.00% |
KNE Stock Forecast | Kane Biotech | - |
0
|
C$0.13 | Buy/Sell | C$0.00 | -100.00% |